Mosaic Immunoengineering Stock Current Asset
| CPMV Stock | USD 0.40 0.03 8.11% |
Fundamental analysis of Mosaic Immunoengineerin allows traders to better anticipate movements in Mosaic Immunoengineerin's stock price by examining its financial health and performance throughout various phases of its business cycle.
Mosaic |
Mosaic Immunoengineering OTC Stock Current Asset Analysis
Mosaic Immunoengineerin's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Mosaic Immunoengineering has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Mosaic Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mosaic Immunoengineerin's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mosaic Immunoengineerin could also be used in its relative valuation, which is a method of valuing Mosaic Immunoengineerin by comparing valuation metrics of similar companies.Mosaic Immunoengineerin is currently under evaluation in current asset category among its peers.
Mosaic Fundamentals
| Return On Asset | -4.2 | |||
| Current Valuation | 10.22 M | |||
| Shares Outstanding | 7.24 M | |||
| Shares Owned By Insiders | 88.73 % | |||
| Price To Book | 9.33 X | |||
| EBITDA | (3.52 M) | |||
| Net Income | (3.68 M) | |||
| Cash And Equivalents | 205.99 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 735.15 K | |||
| Current Ratio | 0.07 X | |||
| Book Value Per Share | (0.60) X | |||
| Cash Flow From Operations | (679.24 K) | |||
| Earnings Per Share | (0.51) X | |||
| Beta | -1.79 | |||
| Market Capitalization | 6.01 M | |||
| Total Asset | 269.49 K | |||
| Z Score | -38.1 | |||
| Net Asset | 269.49 K |
About Mosaic Immunoengineerin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mosaic Immunoengineering's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mosaic Immunoengineerin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mosaic Immunoengineering based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.